56850-91-0

Usage

Uses

Used in Organic Synthesis:
METHYL 4-(2-BROMOETHOXY)BENZENECARBOXYLATE is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure allows for the creation of a wide range of molecules with diverse applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, METHYL 4-(2-BROMOETHOXY)BENZENECARBOXYLATE is used as a key component in the development of new drugs. Its versatility in organic synthesis enables the production of pharmaceuticals with specific therapeutic properties.
Used in Agrochemical Industry:
METHYL 4-(2-BROMOETHOXY)BENZENECARBOXYLATE is also utilized in the agrochemical industry as a building block for the synthesis of various agrochemicals, such as pesticides and herbicides, contributing to the development of effective solutions for agricultural challenges.
Used in Research and Development:
METHYL 4-(2-BROMOETHOXY)BENZENECARBOXYLATE is employed in research and development settings as a valuable tool for exploring new chemical reactions and pathways, further expanding the scope of its applications in various fields.

InChI:InChI=1/C10H11BrO3/c1-13-10(12)8-2-4-9(5-3-8)14-7-6-11/h2-5H,6-7H2,1H3

Upstream product

• 3204-73-7 4-(2-hydroxyethoxy)benzoic acid methyl ester 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 106-93-4 ethylene dibromide 
• 557-91-5 1,1-Dibromoethane 

Downstream Products

• 127531-53-7 N-acetyl-N,N'-di-<2-(4-methoxycarbonyl)phenoxyethyl>ethylenediamine 
• 127531-52-6 1-<2-(4-methoxycarbonyl)phenoxyethyl>-2-methylimidazoline 
• 51616-09-2 4-(β-bromoethoxy)benzoic acid 
• 402477-59-2 methyl 4{2-[2-(2,2,2-trifluoroacetylimino)-2H-pyrid in-1-yl]ethoxy}benzoate 
• 215656-70-5 4-[2-(2-Oxopyrrolidin-1-yl)ethoxy]benzoic Acid 
• 3195-95-7 sodium salt of 2-pyrrolidinone 
• 215656-66-9 4-[2-(1-Pyrazolyl)ethoxy]benzoic Acid Hydrochloride 
• 40958-82-5 sodium pyrazolide 
• 113459-58-8 N-[2-(4-Methoxycarbonylphenoxy)ethyl]phthalimide 
• 56850-93-2 methyl 4-(2-Aminoethyloxy)benzoate 
• 1035269-39-6 4-[2-(4,4-difluoro-1-piperidyl)ethoxy]-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]benzamide 
• 92501-87-6 methyl 4-(2-morpholinoethoxy)benzoate 
• 869299-53-6 methyl 1-[2-({4-[(methyloxy)carbonyl]phenyl}oxy)ethyl]-4-nitro-1H-pyrazole-5-carboxylate 
• 869299-54-7 methyl 1-[2-({4-[(methyloxy)carbonyl]phenyl}oxy)ethyl]-4-nitro-1H-pyrazole-3-carboxylate 

Relevant academic research and scientific papers

Double-target inhibitor targeting FGFR (fibroblast growth factor receptor) and HDAC (histone deacetylase) as well as preparation method and application thereof, pharmaceutical composition and medicament

The invention discloses a double-target inhibitor targeting FGFR (fibroblast growth factor receptor) and HDAC (histone deacetylase) as well as a preparation method and application thereof, a pharmaceutical composition and a medicament, and belongs to the

Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2AReceptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents

Adenosine is an immunosuppressive factor in the tumor microenvironment mainly through activation of the A2A adenosine receptor (A2AR), which is a mechanism hijacked by tumors to escape immune surveillance. Small-molecule A2AR antagonists are being evaluat

Pyrene-containing water-soluble dye and preparation method thereof

The invention discloses a pyrene-containing water-soluble dye. The general formula of the pyrene-containing water-soluble dye is shown as a formula I. The pyrene-containing water-soluble dye with thewidened fluorescence emission spectrum is reasonable in

INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY

The present disclosure relates to compounds that are capable of modulating the WNT/Beta-Catenin pathway. The disclosure further relates to methods of treating colorectal cancer and other WNT/Beta-Catenin mediated cancers.

New rosiglitazone analogue, preparation method and applications thereof

The invention relates to a rosiglitazone analogue, a preparation method and applications thereof, wherein the compound has a structure represented by the following formula (I), R1 represents C3-10 cycloalkyl unsubstituted or optionally substituted by the

Naphthylamine compound and biologically acceptable salt thereof as well as preparation method and application thereof

Aiming at shortage of anti-cancer targeting medicines in the prior art, the invention provides a naphthylamine compound and a biologically acceptable salt thereof as well as a preparation method and application thereof. By adopting the naphthylamine compo

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Discovery of Novel 2-(piperidin-4-yl)-1H-benzo[d]imidazole Derivatives as Potential Anti-Inflammatory Agents

A novel 2-(piperidin-4-yl)-1H-benzo[d]imidazole derivative 5 with good anti-inflammatory activity was identified from our in-house library. Based on hit compound 5, two series of 2-(piperidin-4-yl)-1H-benzo[d]imidazole derivative 6a-g and 7a-h were designed and synthesized as novel anti-inflammatory agents. Most of synthesized compounds exhibited good inhibitory activity on NO and TNF-α production in LPS-stimulated RAW 264.7 macrophages, in which the compound 6e showed most potent inhibitory activity on NO (IC50 = 0.86 μm) and TNF-α (IC50 = 1.87 μm) production. Further evaluation revealed that compound 6e displayed more potent in vivo anti-inflammatory activity than ibuprofen did on xylene-induced ear oedema in mice. Additionally, Western blot analysis revealed that compound 6e could restore phosphorylation level of IκBα and protein expression of p65 NF-κB in LPS-stimulated RAW 264.7 macrophages.

Development of unsymmetrical dyads as potent noncarbohydrate-based inhibitors against human β-N-acetyl-D-hexosaminidase

Human β-N-acetyl-D-hexosaminidase has gained much attention due to its roles in several pathological processes and been considered as potential targets for disease therapy. A novel and efficient skeleton, which was an unsymmetrical dyad containing naphthalimide and methoxyphenyl moieties with an alkylamine spacer linkage as a noncarbohydrate-based inhibitor, was synthesized, and the activities were valuated against human β-N-acetyl-D- hexosaminidase. The most potent inhibitor exhibits high inhibitory activity with Ki values of 0.63 μM. The straightforward synthetic manners of these unsymmetrical dyads and understanding of the binding model could be advantageous for further structure optimization and development of new therapeutic agents for Hex-related diseases.

METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS

Methods of using semi-synthetic glycopeptides of formula I-XIV having antibacterial activity are described.